Drug intelligence / Profile preview

Su Yin Jie Du Ke Li

Development stage: Preclinical
Administration: Oral

Overview

Su Yin Jie Du Ke Li (苏茵解毒颗粒) is a Traditional Chinese Medicine (TCM) herbal formula developed as a clinical experience formula from Jiangsu Province, China. It is primarily used for the intervention and treatment of chronic renal failure. The formula is composed of 12 distinct herbs and is traditionally understood to have the efficacy of benefiting the kidney and detoxifying the body, aligning with TCM principles for addressing kidney-related conditions.

Other names: 苏茵解毒颗粒

Targets

MAP3K9 (Mixed lineage kinase 1)NOX2 (NADPH oxidase 2)TNFA (Tumor necrosis factor alpha (soluble))FXR (Farnesoid x-activated receptor)

Beyond the preview

Go deeper on Su Yin Jie Du Ke Li.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Su Yin Jie Du Ke Li.

Explore the full profile